Loading company…
Oakland-based medical diagnostics company developing a compound to prevent local lipolysis.
Founded in 2010 and based in California, US, Rhamnopharma, Inc. develops a compound to prevent local lipolysis. The company says the compound allows the disease to be diagnosed at an early stage, so patients can be treated before it progresses.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in